In addition to a putative prominent role of IL-6 in seronegative RA, another study demonstrated a distinct cytokine profile of patients with early ACPA/RF-negative disease, with increased IL-10 and decreased IL-1ß, IL-15 and eotaxin in levels in comparison with patients with seropositive RA (281). Here, IL6 is linked to rheumatoid arthritis.